220 related articles for article (PubMed ID: 23842639)
1. The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials.
Cauley JA
Curr Osteoporos Rep; 2013 Sep; 11(3):171-8. PubMed ID: 23842639
[TBL] [Abstract][Full Text] [Related]
2. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
[TBL] [Abstract][Full Text] [Related]
3. The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative.
Jackson RD; Shidham S
Curr Osteoporos Rep; 2007 Dec; 5(4):153-9. PubMed ID: 18430389
[TBL] [Abstract][Full Text] [Related]
4. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
[TBL] [Abstract][Full Text] [Related]
5. Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.
Mullins CD; Ohsfeldt RL
J Manag Care Pharm; 2003; 9(2):150-8. PubMed ID: 14613344
[TBL] [Abstract][Full Text] [Related]
6. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
7. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
9. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
[TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
[TBL] [Abstract][Full Text] [Related]
11. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.
Jackson RD; Wright NC; Beck TJ; Sherrill D; Cauley JA; Lewis CE; LaCroix AZ; LeBoff MS; Going S; Bassford T; Chen Z
Calcif Tissue Int; 2011 Mar; 88(3):198-208. PubMed ID: 21253715
[TBL] [Abstract][Full Text] [Related]
12. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
Bolland MJ; Grey A; Avenell A; Gamble GD; Reid IR
BMJ; 2011 Apr; 342():d2040. PubMed ID: 21505219
[TBL] [Abstract][Full Text] [Related]
13. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.
Bolland MJ; Grey A; Gamble GD; Reid IR
Am J Clin Nutr; 2011 Oct; 94(4):1144-9. PubMed ID: 21880848
[TBL] [Abstract][Full Text] [Related]
14. Calcium plus vitamin D supplementation and the risk of fractures.
Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
[TBL] [Abstract][Full Text] [Related]
15. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
Prentice RL; Pettinger MB; Jackson RD; Wactawski-Wende J; Lacroix AZ; Anderson GL; Chlebowski RT; Manson JE; Van Horn L; Vitolins MZ; Datta M; LeBlanc ES; Cauley JA; Rossouw JE
Osteoporos Int; 2013 Feb; 24(2):567-80. PubMed ID: 23208074
[TBL] [Abstract][Full Text] [Related]
16. Calcium supplementation and fracture risk--recent findings from the women's health initiative study.
Kruse H
S D Med; 2006 May; 59(5):207-8. PubMed ID: 16729654
[No Abstract] [Full Text] [Related]
17. Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
Schnatz PF; Jiang X; Aragaki AK; Nudy M; O'Sullivan DM; Williams M; LeBlanc ES; Martin LW; Manson JE; Shikany JM; Johnson KC; Stefanick ML; Payne ME; Cauley JA; Howard BV; Robbins J
Obstet Gynecol; 2017 Jan; 129(1):121-129. PubMed ID: 27926633
[TBL] [Abstract][Full Text] [Related]
18. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
[TBL] [Abstract][Full Text] [Related]
19. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
Jackson RD; Mysiw WJ
Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
[TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
